Gen Z Drives Bargain Hunting Trend Boosting Discount Retailers Like Walmart and Ross Nvidia and Leading Asian Chipmakers Ride the AI Surge Oil Prices Slip Weekly as USIran Deal Talks Show Progress but Key Hurdles Remain Intel Pushes PC Makers to Adopt 18A Chips as AI Demand Fuels Semiconductor Growth Estate Transparency Concerns Family Accuses Executor of Potential Mismanagement London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance ESLA Q1 2026 Earnings WiderThanExpected Loss and No Revenue Highlight DevelopmentStage Challenges HOVR Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Focuses on Development CNP Q1 2026 Earnings Slight EPS Miss but Stock Gains on Operational Stability SLAI Q4 2024 Earnings EPS Misses Estimates as Company Reports Loss per Share Acushnet Holdings GOLF Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher WGRX Q1 2026 Earnings Heavy Loss and Steep Selloff as Transparency Remains Limited South Plains Financial Inc SPFI Edges Lower Analyzing Key Support and Resistance Levels INAC Holds Steady at 1021 Indigo Acquisition Corp Shows Minimal Price Movement StableX Technologies SBLX Holds Steady at 31 as Market Awaits Direction DAAQW Warrants Hold Steady at 050 Amid Low Volatility Key Levels in Focus Bausch Health Edges Higher Evaluating Key Support and Resistance Levels for BHC Stock Danaos Corporation Q1 2026 Earnings Slight EPS Miss Despite Solid Operations Ouster Inc OUST Q1 2026 Earnings NarrowerThanExpected Loss and Strong Stock Rally Cytokinetics Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Takes Center Stage Cavco Industries Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction KYMR Q1 2026 Earnings PreRevenue Biotech Beats EPS Estimates Stock Edges Lower Flanigans Enterprises Inc BDL Q3 2025 Earnings Positive EPS Performance Despite Lack of Consensus Estimates TCS Partners with Mistral to Become First Global Systems Integrator for Enterprise AI VUZI Q1 2026 Earnings Narrowed Loss Surprises Revenue Remains Absent Ocugen Inc OCGN Rallies 3 as Biotech Stock Tests Key Resistance Near 145